Bethesda Diabetes Research Center

Bethesda Diabetes Research Center (BDRC) is a specialized clinical research institute located in Hoogeveen, Netherlands, focused on advancing the treatment of diabetes and its cardiovascular complications. The center is led by Dr. Adriaan Kooy and is well-known for its leadership in significant clinical trials, including the HOME and POEM studies, which evaluate the long-term metabolic and vascular effects of metformin and insulin. BDRC operates as a private limited company (B.V.) and serves as a key site for international pharmaceutical trials in metabolic diseases. By bridging the gap between clinical practice and academic research, the center aims to deliver personalized medicine solutions that improve the quality of life for patients with Type 2 and gestational diabetes.